Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04875377
Other study ID # 133109
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 12, 2018
Est. completion date September 5, 2019

Study information

Verified date January 2023
Source University of Glasgow
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this project, the investigators propose an intervention design testing the efficacy of a food reformulated with seaweed as an ingredient in meal, capsules against placebo and no intervention controls. The randomised control trial (supplementation) will last 24 weeks. The aim is to study the effect of the food matrix on variables associated with iodine nutrition: iodine status and thyroid function.


Description:

This study is a randomized, double-blind, placebo-controlled trial conducted in Glasgow, United Kingdom. Inclusion criteria are as follows: healthy premenopausal women aged 18 - 60 years who would remain a resident in Glasgow for 24 weeks; who were self-reported low iodine consumers consuming milk less than once per day and non-oily fish less than once per week. Those with a history of thyroid dysfunction, taking medications other than the contraceptive pill or smoking, as well as pregnant or lactating women and those planning to conceive, were excluded. Those taking dietary supplements containing iodine would also excluded and there was no restriction related to body mass index (BMI). Participants are recruited via social media and advertisements displayed around the Greater Glasgow area. Interested parties are screened and, if eligible, invited to a 30-minute appointment at which participants were randomly assigned through a web-based randomisation service to one of four groups after consent is obtained; reformulated pizza, control pizza, iodine capsules, or placebo capsules. During this initial meeting anthropometric measurements, blood pressure and a venous blood sample are collected, and participants are also asked to complete a sociodemographic questionnaire and an iodine specific food frequency questionnaire (FFQ). Participants are provided with instructions and equipment to record a 3-day estimated food diary and to collect 12 spot urine samples at different times of day over 2-7 days. Upon returning the spot urine samples, participants were given either the pizzas or supplements to begin the intervention. Participants are asked to consume one pizza or supplement three times a week for 24 weeks. Participants are asked to collect a further 10-12 sample spot urine samples at week 2 of the intervention. Participants are asked to attend another 30-minute appointment at 12 and 24 weeks in which baseline measurements are repeated along with a change to diet questionnaire.


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date September 5, 2019
Est. primary completion date September 5, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - self-reported healthy women - aged 18 to 60 - pre-menopausal - with no history of thyroid dysfunction - without any known allergic reactions to foods - not on medication that impact on absorption of nutrients from the gut - not currently taking dietary / multivitamin supplements (must have discontinued usage 2 weeks prior the start of the study) Exclusion Criteria: - pregnancy - lactation - habitual consumption of seaweed-based products (>once per week), milk (>once per day), sea fish, non-oily, e.g. cod (>once per week) - veganism (as food products contains cheese) - Involvement in another research study where diet is restricted, modified, or dietary habits are studied. - women who have reached menopause.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Reformulated pizza
Reformulated food with 400ug of iodine per meal, three times per week (to achieve 122% of weekly recommended intakes - average 140ug/day).
Control pizza
Control (placebo) meal to consume thrice weekly (no iodine supplementation).
Seaweed capsule
Capsules containing seaweed extract, the iodine-rich ingredient in the reformulated pizza, 400ug iodine per capsule, to be consumed three times per week (122% of weekly recommended intake).
Control capsule
Empty capsules (placebo)

Locations

Country Name City State
United Kingdom University of Glasgow Glasgow

Sponsors (1)

Lead Sponsor Collaborator
University of Glasgow

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other concentration of triglycerides measured in blood 0, 12, 24 weeks
Other concentration of total cholesterol measured in blood 0, 12, 24 weeks
Other concentration of HDL/LDL cholesterol measured in blood 0, 12, 24 weeks
Other glucose concentration measured in blood 0, 12, 24 weeks
Primary Change in urinary iodine concentration (UIC) Change in UIC assessed in pooled spot urine samples at 12 weeks, from baseline 0, 12 weeks
Primary Change in urinary iodine concentration (UIC) Change in UIC assessed in pooled spot urine samples at 24 weeks, from baseline 0, 24 weeks
Secondary Changes in body weight Changes in body weight assessed from baseline at 12 and 24 weeks 0, 12, 24 weeks
Secondary Changes in body mass index Changes in body mass index assessed from baseline at 12 and 24 weeks 0, 12, 24 weeks
Secondary Changes in waist circumference Changes in waist circumference assessed from baseline at 12 and 24 weeks 0, 12, 24 weeks
Secondary Concentration of thyroid stimulating hormone measured by immunoassay 0, 12, 24 weeks
Secondary Concentration of thyroglobulin measured by immunoassay 0, 12, 24 weeks
Secondary Concentration of Free Triiodothyronine measured by immunoassay 0, 12, 24 weeks
Secondary Concentration of Thyroxine measured by immunoassay 0, 12, 24 weeks
Secondary Dietary iodine intake estimated by food frequency questionnaire (FFQ) 0, 12, 24 weeks
Secondary Change in urinary iodine concentration (UIC) Change in UIC assessed in pooled spot urine samples at 2 weeks, from baseline 0, 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT00791466 - Maternal Iodine Supplementation and Effects on Thyroid Function and Child Development N/A
Completed NCT05724251 - Effect of Iodine Deficiency on Periodontitis
Completed NCT01349634 - The Effects of Iodized Salt on Cognitive Development in Ethiopia N/A
Completed NCT05170997 - Strategies to Improve Iodine Status in Early Pregnancy N/A
Completed NCT03731312 - Variability of Daily Iodine Intake: The Effects of Intra- and Inter-individual Variability in Iodine Nutrition Studies
Completed NCT02280330 - Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months Phase 4
Completed NCT01985204 - Iodine Supplementation in Obesity N/A
Withdrawn NCT01301768 - Group Education to Improve the Iodine Nutrition in Pregnancy: Cluster Randomized Trial N/A
Completed NCT03279315 - An Iodine Balance Experiment N/A
Not yet recruiting NCT05901766 - Effect of Iodine-containing Multiple Micronutrient During Lactation on Infant Neurodevelopment Phase 4
Completed NCT01126125 - Study of the Effect of Iodized Oil Supplementation During Infancy N/A
Recruiting NCT00505479 - Iodine Status in Pregnant Women and Their Newborns: is Congenital Hypothyroidism Related to Iodine Deficiency in Pregnancy? N/A
Recruiting NCT05382793 - Assessment of the Daily Average Requirement of Iodine in Lactating Women N/A
Completed NCT03078140 - Iodine Supplement Strategies Between Routine Iodine Supplementation and Selective Iodine Supplementation N/A
Completed NCT05685056 - Nutrition & Food Choices in Early Pregnancy N/A
Enrolling by invitation NCT05792241 - Acceptability and Nutritional Impact of Double-fortified Salt Containing Iodine and Folic Acid - Phase 1
Completed NCT03602404 - Estimating Usual Iodine Intake From Spot Urinary Iodine Concentrations
Completed NCT02196337 - Salt Iodization: Meeting the Needs of Pregnancy, Lactation and Infancy N/A
Completed NCT03215680 - Climat Impact on Urinary Iodine Concentration
Recruiting NCT03377218 - Potential Preventive Effect of Selenium on Iodine-induced Thyroid Autoimmunity During Pregnancy N/A